Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17680861rdf:typepubmed:Citationlld:pubmed
pubmed-article:17680861lifeskim:mentionsumls-concept:C0039593lld:lifeskim
pubmed-article:17680861lifeskim:mentionsumls-concept:C0994894lld:lifeskim
pubmed-article:17680861lifeskim:mentionsumls-concept:C0047822lld:lifeskim
pubmed-article:17680861pubmed:issue3lld:pubmed
pubmed-article:17680861pubmed:dateCreated2007-8-7lld:pubmed
pubmed-article:17680861pubmed:abstractTextWe have previously shown that patch test preparations of polymeric diphenylmethane diisocyanate (PMDI) are more stable than preparations of diphenylmethane-4,4'-diisocyanate (4,4'-MDI). This study was conducted to (i) investigate whether PMDIs yield as many positive reactions as 4,4'-MDI, (ii) study concurrent reactions to 4,4'-MDI and 4,4'-diaminodiphenylmethane (4,4'-MDA), and (iii) follow the course of positive reactions during 4 weeks. It was shown that PMDIs detect as many positive reactions as 4,4'-MDI. Thus, they are better patch test agents being more stable than preparations of 4,4'-MDI. We recommend that PMDIs with a monomer content of at least 35% is used in 2.0% petrolatum (pet.) (i.e. monomer patch test concentration approximately 0.7%). It was shown that reactions to 4,4'-MDI and PMDIs appear late and we recommend readings on both day (D) 3/4 and D7. 4,4'-MDA was shown to be a good marker for 4,4'-MDI and patch testing with 4,4'-MDA in 0.25% pet. can be used instead of PMDI. Concomitant reactions to 4,4'-MDI and 4,4'-MDA are probably not caused by conversion of 4,4'-MDI into 4,4'-MDA by reaction with water. Another explanation is a path of reactions leading to ureas and MDI conjugates with skin constituents, which are hydrolysed into 4,4'-MDA. This complex process depends upon several factors and might explain why positive MDI reactions appear after D7.lld:pubmed
pubmed-article:17680861pubmed:languageenglld:pubmed
pubmed-article:17680861pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17680861pubmed:citationSubsetIMlld:pubmed
pubmed-article:17680861pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17680861pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17680861pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17680861pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17680861pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17680861pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17680861pubmed:statusMEDLINElld:pubmed
pubmed-article:17680861pubmed:monthSeplld:pubmed
pubmed-article:17680861pubmed:issn0105-1873lld:pubmed
pubmed-article:17680861pubmed:authorpubmed-author:BruzeMagnusMlld:pubmed
pubmed-article:17680861pubmed:authorpubmed-author:IsakssonMarlé...lld:pubmed
pubmed-article:17680861pubmed:authorpubmed-author:ZimersonErikElld:pubmed
pubmed-article:17680861pubmed:authorpubmed-author:Frick-Engfeld...lld:pubmed
pubmed-article:17680861pubmed:issnTypePrintlld:pubmed
pubmed-article:17680861pubmed:volume57lld:pubmed
pubmed-article:17680861pubmed:ownerNLMlld:pubmed
pubmed-article:17680861pubmed:authorsCompleteYlld:pubmed
pubmed-article:17680861pubmed:pagination138-51lld:pubmed
pubmed-article:17680861pubmed:meshHeadingpubmed-meshheading:17680861...lld:pubmed
pubmed-article:17680861pubmed:meshHeadingpubmed-meshheading:17680861...lld:pubmed
pubmed-article:17680861pubmed:meshHeadingpubmed-meshheading:17680861...lld:pubmed
pubmed-article:17680861pubmed:meshHeadingpubmed-meshheading:17680861...lld:pubmed
pubmed-article:17680861pubmed:meshHeadingpubmed-meshheading:17680861...lld:pubmed
pubmed-article:17680861pubmed:meshHeadingpubmed-meshheading:17680861...lld:pubmed
pubmed-article:17680861pubmed:meshHeadingpubmed-meshheading:17680861...lld:pubmed
pubmed-article:17680861pubmed:meshHeadingpubmed-meshheading:17680861...lld:pubmed
pubmed-article:17680861pubmed:meshHeadingpubmed-meshheading:17680861...lld:pubmed
pubmed-article:17680861pubmed:meshHeadingpubmed-meshheading:17680861...lld:pubmed
pubmed-article:17680861pubmed:meshHeadingpubmed-meshheading:17680861...lld:pubmed
pubmed-article:17680861pubmed:meshHeadingpubmed-meshheading:17680861...lld:pubmed
pubmed-article:17680861pubmed:meshHeadingpubmed-meshheading:17680861...lld:pubmed
pubmed-article:17680861pubmed:year2007lld:pubmed
pubmed-article:17680861pubmed:articleTitleHow to optimize patch testing with diphenylmethane diisocyanate.lld:pubmed
pubmed-article:17680861pubmed:affiliationDepartment of Occupational and Environmental Dermatology, Malmö University Hospital, Lund University, S-205 02 Malmö, Sweden. malin.frick@med.lu.selld:pubmed
pubmed-article:17680861pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17680861pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:17680861pubmed:publicationTypeEvaluation Studieslld:pubmed